Last reviewed · How we verify
NCT03957278
A Study to Evaluate the DAISe System During Neurointervention for Acute Ischemic Stroke
NA trial testing DAISe System in Stroke, Acute in 4 participants. Terminated before completion.
1 May 2020
Quick facts
| Lead sponsor | MIVI Neuroscience, Inc. |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 4 |
| Start date | 15 August 2019 |
| Primary completion | 1 May 2020 |
| Estimated completion | 9 November 2021 |
| Sites | 2 locations across Belgium |
Drugs / interventions tested
- DAISe System
Conditions studied
- Stroke, Acute — all drugs for Stroke, Acute →
Sponsor
MIVI Neuroscience, Inc.
Who can join
Adults 18 to 85, any sex, with Stroke, Acute. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This purpose study is to demonstrate the safety and performance of the DAISe System used to remove clot in the brain during a stroke. This study will assess how well the device removes clot from the brain and how well patients recover from their stroke. This study plans to enroll 100 study patients at up to 10 hospitals in Europe. Study patients are followed for 3 months after the procedure.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03957278
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stroke, Acute
Currently open trials in the same condition.
- NCT06825897 — Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiograp · NA · recruiting
- NCT06658197 — Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke · Phase 3 · recruiting
- NCT07253870 — Comperative Effects of Transcutaneous Auricular and Cervical Vagus Nerve Stimulation in Subacute Stroke Patients · NA · recruiting
- NCT06941753 — Off-script Diagnosis & Differential Diagnosis (D&D) Training and Residents' Stroke Knowledge · NA · recruiting
- NCT06123650 — Post Stroke Dysphagia: Effect of Adding rTMS to Conventional Therapy on the Prevalence of Pneumonia. · NA · recruiting
Other MIVI Neuroscience, Inc. trials
Trials by the same sponsor.
- NCT05631483 — COlombia DAISe FEasibility Exercise · NA · terminated
- NCT05139147 — DAISe 1 Feasibility Study to Evaluate the DAISe Thrombectomy System for Acute Ischemic Stroke · NA · terminated
- NCT04437862 — A Study to Evaluate the Q Revascularization System for Neurointervention in Acute Ischemic Stroke · NA · completed
- NCT04089917 — A Study of the Use of the Q Aspiration Catheter to Remove Clot in Stroke Patients · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03957278 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by MIVI Neuroscience, Inc.
- Last refreshed: 20 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03957278.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing